SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma gets EIR from USFDA for Telangana manufacturing facility

18 May 2026 Evaluate

Piramal Pharma has received Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (USFDA) for its manufacturing facility located at Digwal, Telangana, India. The receipt of said EIR marks successful closure of the inspection.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. 


Piramal Pharma Share Price

168.10 -1.45 (-0.86%)
05-Jun-2026 09:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.10
Dr. Reddys Lab 1272.70
Cipla 1392.10
Zydus Lifesciences 1089.90
Lupin 2281.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×